Catch up on the top radiology content of the past week.
News|Articles|October 3, 2026
Emerging Research Insights and New Advances in Neuroradiology
Author(s)Diagnostic Imaging Staff
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Advertisement
Advertisement
Will a new positron emission tomography (PET) agent be a game changer for glioma imaging? Are patients with diabetes and lower bone mineral density (BMD) on chest CT more susceptible to faster accumulation of white matter hyperintensity (WMH)? Can newly FDA-cleared software facilitate improved quality of amyloid PET imaging via structural MRI?
Related to this article
Catch up on the top radiology content of the past week.
Catch up on the top AI-related news and research in radiology over the past month.
Catch up on a variety of FDA news in radiology from the past week.
Catch up on the top radiology content of the past week.
Newly published preclinical research signals a substantial conceptual shift with a potential role of photon-counting CT in targeting specific biological processes.
Catch up on the latest imaging research presented at the recent American Society for Radiation Oncology (ASTRO) Annual Meeting.
Catch up on the top radiology content of the past week.
Advertisement
Advertisement